Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024)

Historic Interest Coverage Ratio for Seres Therapeutics (MCRB) over the last 5 years, with Q1 2024 value amounting to 55.72.

  • Seres Therapeutics' Interest Coverage Ratio fell 5382.63% to 55.72 in Q1 2024 from the same period last year, while for Dec 2024 it was 196.3, marking a year-over-year decrease of 88194.47%. This contributed to the annual value of 79.05 for FY2023, which is 16450.69% down from last year.
  • As of Q1 2024, Seres Therapeutics' Interest Coverage Ratio stood at 55.72, which was down 5382.63% from 15.54 recorded in Q2 2023.
  • In the past 5 years, Seres Therapeutics' Interest Coverage Ratio ranged from a high of 91.94 in Q3 2021 and a low of 66.98 during Q4 2021
  • Its 5-year average for Interest Coverage Ratio is 28.48, with a median of 36.23 in 2023.
  • The largest annual percentage gain for Seres Therapeutics' Interest Coverage Ratio in the last 5 years was 32376.99% (2021), contrasted with its biggest fall of 18404.63% (2021).
  • Quarter analysis of 5 years shows Seres Therapeutics' Interest Coverage Ratio stood at 23.58 in 2020, then crashed by 184.05% to 66.98 in 2021, then soared by 98.63% to 0.92 in 2022, then soared by 1787.7% to 15.54 in 2023, then crashed by 458.6% to 55.72 in 2024.
  • Its last three reported values are 55.72 in Q1 2024, 15.54 for Q2 2023, and 36.23 during Q1 2023.